(Press-News.org) Taking B vitamins doesn't slow mental decline as we age, nor is it likely to prevent Alzheimer's disease, conclude Oxford University researchers who have assembled all the best clinical trial data involving 22,000 people to offer a final answer on this debate.
High levels in the blood of a compound called homocysteine have been found in people with Alzheimer's disease, and people with higher levels of homocysteine have been shown to be at increased risk of Alzheimer's disease. Taking folic acid and vitamin B-12 are known to lower levels of homocysteine in the body, so this gave rise to the 'homocysteine hypothesis' that taking B vitamins could reduce the risk of Alzheimer's disease.
The new analysis was carried out by the B-Vitamin Treatment Trialists' Collaboration, an international group of researchers led by the Clinical Trial Service Unit at the University of Oxford. The researchers brought together data from 11 randomised clinical trials involving 22,000 people which compared the effect of B vitamins on cognitive function in older people against placebo. Participants receiving B vitamins did see a reduction in the levels of homocysteine in their blood by around a quarter. However, this had no effect on their mental abilities.
When looking at measures of global cognitive function – or scores for specific mental processes such as memory, speed or executive function – there was no difference between those on B vitamins and those receiving placebo to a high degree of accuracy.
'It would have been very nice to have found something different,' says Dr Robert Clarke of Oxford University, who led the work. 'Our study draws a line under the debate: B vitamins don't reduce cognitive decline as we age. Taking folic acid and vitamin B-12 is sadly not going to prevent Alzheimer's disease.'
The study was funded by the British Heart Foundation, the UK Medical Research Council (MRC), Cancer Research UK, the UK Food Standards Agency and the Department of Health. The findings are published in the American Journal of Clinical Nutrition.
'Taking supplements like B vitamins doesn't prevent heart disease, stroke or cognitive decline,' says Professor Clarke. 'About 25% of the adult population take multi-vitamins, often with the idea that they are also good for the heart or the brain, but the evidence just isn't there. Much better is to eat more fruit and vegetables, avoid too much red meat and too many calories, and have a balanced diet.'
Maternal folic acid intake before and during early pregnancy reduces a woman's risk of having a neural tube defect birth defect and those thinking of having a baby are routinely advised to take folic acid supplements. Countries that have adopted mandatory population-wide folic acid fortification programmes have also demonstrated reductions in neural-tube defect associated pregnancies without any adverse effects.
Dr Simon Ridley, Head of Research at Alzheimer's Research UK, said:
'Although one trial in 2010 showed that for people with high homocysteine, B vitamins had some beneficial effect on the rate of brain shrinkage, this comprehensive review of several trials shows that B vitamins have not been able to slow mental decline as we age, nor are they likely to prevent Alzheimer's. While the outcome of this new and far reaching analysis is not what we hoped for, it does underline the need for larger studies to improve certainty around the effects of any treatment.
'Alzheimer's is feared by many and it's natural that people want to take action to try to prevent the disease, but people should always speak to their GP before changing their diet to include vitamin supplements. Research to understand how to prevent Alzheimer's must continue, and in the meantime evidence shows that a number of simple lifestyle changes can help reduce the risk of the disease. Eating a healthy, balanced diet, taking regular exercise and keeping blood pressure and weight in check can all help lower the risk of Alzheimer's.'
Dr James Pickett, Head of Research at Alzheimer's Society said:
'Given that many previous studies have shown that vitamin B doesn't slow the progression of dementia or reduce risk, it's not a huge surprise that a review of all of the evidence finds much the same. While taking B vitamins may not help everyone, they may have some benefits in specific groups of people with dementia. However, this study suggests that we need much more work to establish more evidence for this.
'One in three people over the age of 65 will develop dementia and yet research funding lags behind other conditions and we haven't seen a new treatment made available in a decade. We need to see significantly more investment and recruit the next generation of leaders in research in order to deliver breakthroughs that could prove so vital to those affected by the condition.'
Hugh Perry, chair of the MRC Neurosciences and Mental Health Board, said:
'Science progresses through testing and re-testing previous research and sometimes overturning existing theories. Health advice always needs to be based on the best available data from the largest possible studies and this is even more important when the findings have implications for what we do or don't eat and drink.'
INFORMATION:
Notes to Editors
The paper 'Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals' by Robert Clarke and colleagues is published in the American Journal of Clinical Nutrition.
Reference Clarke R, Bennet D, Parish S, Lewington S, Skeaff M, Eussen SJPM, Lewerin C, Stott DJ, Armitage J, Hankey GJ, Lonn E, Spence D, Galan P, de Groot LC, Halsey J, Dangour AD, Collins R, Grodstein F, on behalf of the B-Vitamin Treatment Trialists' Collaboration. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. American Journal of Clinical Nutrition.2014; 100:657-66.
http://ajcn.nutrition.org/content/early/2014/06/25/ajcn.113.076349.abstract
Oxford University's Medical Sciences Division is one of the largest biomedical research centres in Europe, with over 2,500 people involved in research and more than 2,800 students. The University is rated the best in the world for medicine, and it is home to the UK's top-ranked medical school.
From the genetic and molecular basis of disease to the latest advances in neuroscience, Oxford is at the forefront of medical research. It has one of the largest clinical trial portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery.
A great strength of Oxford medicine is its long-standing network of clinical research units in Asia and Africa, enabling world-leading research on the most pressing global health challenges such as malaria, TB, HIV/AIDS and flu. Oxford is also renowned for its large-scale studies which examine the role of factors such as smoking, alcohol and diet on cancer, heart disease and other conditions.
Taking B vitamins won't prevent Alzheimer's disease
2014-07-15
ELSE PRESS RELEASES FROM THIS DATE:
How strongly does tissue decelerate the therapeutic heavy ion beam?
2014-07-15
Irradiation with heavy ions is suitable in particular for patients suffering from cancer with tumours which are difficult to access, for example in the brain. These particles hardly damage the penetrated tissue, but can be used in such a way that they deliver their maximum energy only directly at the target: the tumour. Research in this relatively new therapy method is focussed again and again on the exact dosing: how must the radiation parameters be set in order to destroy the cancerous cells "on the spot" with as low a damage as possible to the surrounding tissue? The ...
New hope for treatment of Alzheimer's disease
2014-07-15
Montreal, July 15 2014 - Judes Poirier, PhD, C.Q., from the Douglas Mental Health Institute and McGill University in Montréal (Canada) and his team have discovered that a relatively frequent genetic variant actually conveys significant protection against the common form of Alzheimer's disease and can delay the onset of the disease by as much as 4 years. This discovery opens new avenues for treatment against this devastating disease.
Dr. Poirier announced his findings as the annual Alzheimer's Association International Conference was taking place in Copenhagen. This large-scale ...
Smallest Swiss cross -- Made of 20 single atoms
2014-07-15
The manipulation of atoms has reached a new level: Together with teams from Finland and Japan, physicists from the University of Basel were able to place 20 single atoms on a fully insulated surface at room temperature to form the smallest "Swiss cross", thus taking a big step towards next generation atomic-scale storage devices. The academic journal Nature Communications has published their results.
Ever since the 1990s, physicists have been able to directly control surface structures by moving and positioning single atoms to certain atomic sites. A number of atomic ...
Cholesterol activates signaling pathway that promotes cancer
2014-07-15
Everyone knows that cholesterol, at least the bad kind, can cause heart disease and hardening of the arteries. Now, researchers at the University of Illinois at Chicago describe a new role for cholesterol in the activation of a cellular signaling pathway that has been linked to cancer.
The finding is reported in Nature Communications.
Cells employ thousands of signaling pathways to conduct their functions. Canonical Wnt signaling is a pathway that promotes cell growth and division and is most active in embryonic cells during development. Overactivity of this signaling ...
Researchers assess emergency radiology response after Boston Marathon bombings
2014-07-15
OAK BROOK, Ill. – An after-action review of the Brigham and Women's Hospital emergency radiology response to the Boston Marathon bombings highlights the crucial role medical imaging plays in emergency situations and ways in which radiology departments can improve their preparedness for mass casualty events. The new study is published online in the journal Radiology.
"It's important to analyze our response to events like the Boston Marathon bombing to identify opportunities for improvement in our institutional emergency operations plan," said senior author Aaron Sodickson ...
No anti-clotting treatment needed for most kids undergoing spine surgeries
2014-07-15
Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according to a new Johns Hopkins Children's Center study.
Because clotting risk in children is poorly understood, treatment guidelines are largely absent, leaving doctors caring for pediatric patients at a loss on whom to treat and when.
The Johns Hopkins' team findings, published online July 15 in the journal Spine, narrow down the pool of high-risk patients ...
Little too late: Researchers identify disease that may have plagued 700-year-old skeleton
2014-07-15
European researchers have recovered a genome of the bacterium Brucella melitensis from a 700-year-old skeleton found in the ruins of a Medieval Italian village.
Reporting this week in mBio®, the online open-access journal of the American Society for Microbiology, the authors describe using a technique called shotgun metagenomics to sequence DNA from a calcified nodule in the pelvic region of a middle-aged male skeleton excavated from the settlement of Geridu in Sardinia, an island off the coast of Italy. Geridu is thought to have been abandoned in the late 14th century. ...
Study reveals how gardens could help dementia care
2014-07-15
A new study has revealed that gardens in care homes could provide promising therapeutic benefits for patients suffering from dementia.
The research is published in the Journal of the American Medical Directors Association and by critically reviewing the findings from 17 different pieces of research, has found that outdoor spaces can offer environments that promote relaxation, encourage activity and reduce residents' agitation.
Conducted by a team at the University of Exeter Medical School and supported by the National Institute for Health Research Collaboration for ...
Fungicides for crops: Worrying link to fungal drug resistance in UK warns scientists
2014-07-15
Crop spraying on British farms could be aiding a life-threatening fungus suffered by tens of thousand of people in the UK each year.
New research by British and Dutch scientists has found that Aspergillus – a common fungus that attacks the lungs and is found in soil and other organic matter – has become resistant to life - saving drugs in parts of rural Yorkshire.
It's the first time a link has been made in the UK between drug resistance in Aspergillus and fungicide used on crops. Experts warn their findings, now published, are significant and raise serious implications ...
Pre-diabetes label 'unhelpful and unnecessary'
2014-07-15
Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.
The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes by a few years, and found no evidence of long-term health benefits.
Type 2 diabetes is typically diagnosed ...